Juniper Biologics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

  • Investments
  • 1

Juniper Biologics General Information

Description

Operator of a biotechnology company intended to enhance the health and quality of life of cancer patients. The company specializes in researching, developing and commercializing novel therapies, with a focus on oncology, rare or orphan diseases, and gene therapy, enabling healthcare professionals to provide proper treatments to cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1 Wallich Street, Guoco Tower
  • Number 30-01A
  • Singapore, 078881
  • Singapore
+65 6864
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1 Wallich Street, Guoco Tower
  • Number 30-01A
  • Singapore, 078881
  • Singapore
+65 6864

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Juniper Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Juniper Biologics‘s full profile, request access.

Request a free trial

Juniper Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Juniper Biologics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Juniper Biologics‘s full profile, request access.

Request a free trial

Juniper Biologics Investments (1)

Juniper Biologics’s most recent deal was a Buyout/LBO with Artemis Healthcare. The deal was made on 01-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Artemis Healthcare 01-Jan-2021 Buyout/LBO Clinics/Outpatient Services
To view Juniper Biologics’s complete investments history, request access »

Juniper Biologics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Artemis Healthcare Singapore

Juniper Biologics FAQs

  • When was Juniper Biologics founded?

    Juniper Biologics was founded in 2020.

  • Where is Juniper Biologics headquartered?

    Juniper Biologics is headquartered in Singapore, Singapore.

  • What is the size of Juniper Biologics?

    Juniper Biologics has 37 total employees.

  • What industry is Juniper Biologics in?

    Juniper Biologics’s primary industry is Drug Discovery.

  • Is Juniper Biologics a private or public company?

    Juniper Biologics is a Private company.

  • What is the current valuation of Juniper Biologics?

    The current valuation of Juniper Biologics is .

  • What is Juniper Biologics’s current revenue?

    The current revenue for Juniper Biologics is .

  • How much funding has Juniper Biologics raised over time?

    Juniper Biologics has raised $10M.

  • Who are Juniper Biologics’s investors?

    UOB Venture Management and The Sylvan Group have invested in Juniper Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process